You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
15 July 2024
Abivax Provides Operational and Key Program Update
5 April 2024
Abivax publishes financial reports with the French and U.S. securities regulatory agencies
2 April 2024
Abivax reports 2023 financial results and operational update
13 February 2024
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)
7 February 2024
Abivax appoints Ana Sharma as Vice President, Global Head of Quality
2 February 2024
Abivax announces update to obefazimod Phase 2b clinical development program in moderately to severely active Crohn’s disease